• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 456000 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417142337 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417142337 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Biogen Idec (BIIB) Approaches New Upside Target of $173.82

Published on Fri, 03/08/2013 - 13:43
By Peter Chu

Shares of Biogen Idec (NASDAQ:BIIB) opened today above their pivot of $171.82 and have already reached the first level of resistance at $172.65. Should the shares continue to rise, the resistance pivots of $173.82 and $175.82 will be of interest.

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

In the past 52 weeks, Biogen Idec share prices have been bracketed by a low of $116.30 and a high of $173.72 and are now at $172.14, 48% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.0% while the 200-day MA has risen 0.5%.

There is potential upside of 0.9% for shares of Biogen Idec based on a current price of $172.14 and an average consensus analyst price target of $173.75. The stock should find initial support at its 50-day moving average (MA) of $155.42 and further support at its 200-day MA of $147.48.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Watch for Continued Gains in Shares of V...

Shares of Varian Medical Systems (NYSE:VAR) traded at a new 52-week high today of $89.6 ...

UnitedHealth: The Winning Streak Continu...

Shares of UnitedHealth (NYSE:UNH) traded today at $98.74, breaking its 52-week high. A ...

Texas Instruments: 52-Week High Recently...

Shares of Texas Instruments (NYSE:TXN) traded at a new 52-week high today of $53.74. T ...

Recent 52-Week High Exceeded in Shares o...

Taiwan Semiconductor Manufacturing (NYSE:TSM) traded at a new 52-week high today of $23 ...

Shares of Hanover Insurance Rise Above P...

Shares of Hanover Insurance (NYSE:THG) traded at a new 52-week high today of $71.67. T ...

Recent 52-Week High Exceeded in Shares o...

Taubman Centers (NYSE:TCO) traded today at a new 52-week high of $79.47. So far today ...

Shares of Taser International Have Risen...

Taser International (NASDAQ:TASR) traded at a new 52-week high today of $22.35. Approx ...

Shares of Sunstone Hotel Investors Have ...

Sunstone Hotel Investors (NYSE:SHO) traded at a new 52-week high today of $15.93. This ...